Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (191-200 of 361) with videos related to

Pageof 37
Sort By:
Critical Care (London, England)|January 8, 2026
Longitudinal mycological profiling of influenza-associated and COVID-19-associated pulmonary aspergillosisValentine Delanote, Jannes Heylen, Hanne Moon Lauwers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) TrialHanne Lamberink, Sammy Huygens, Robina Aerts, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
The Pediatric Infectious Disease Journal|September 26, 2009
Safety experience with caspofungin in pediatric patientsTheoklis Zaoutis, Thomas Lehrnbecher, Andreas H Groll, et al.
Oncotarget|April 2, 2016
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTomasz Czerw, Myriam Labopin, Christoph Schmid, et al.
American Journal of Hematology|January 1, 2019
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationCatherine J Lee, Myriam Labopin, Dietrich Beelen, et al.
Clinical Hematology International|October 1, 2021
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: <i>In vivo</i> T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant StudyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.
Pageof 37

Showing results (191-200 of 361) with videos related to

Sort By:
Pageof 37
Critical Care (London, England)|January 8, 2026
Longitudinal mycological profiling of influenza-associated and COVID-19-associated pulmonary aspergillosisValentine Delanote, Jannes Heylen, Hanne Moon Lauwers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) TrialHanne Lamberink, Sammy Huygens, Robina Aerts, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
The Pediatric Infectious Disease Journal|September 26, 2009
Safety experience with caspofungin in pediatric patientsTheoklis Zaoutis, Thomas Lehrnbecher, Andreas H Groll, et al.
Oncotarget|April 2, 2016
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTomasz Czerw, Myriam Labopin, Christoph Schmid, et al.
American Journal of Hematology|January 1, 2019
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationCatherine J Lee, Myriam Labopin, Dietrich Beelen, et al.
Clinical Hematology International|October 1, 2021
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: <i>In vivo</i> T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant StudyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.
Pageof 37